Publications by authors named "Mark R Litzow"

100Publications

A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation Patients.

Biol Blood Marrow Transplant 2020 Sep 4;26(9):1627-1634. Epub 2020 Jun 4.

Department of Pharmacy Services, Mayo Clinic Hospital, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.05.020DOI Listing
September 2020

The increasing complexity of the management of core-binding factor acute myeloid leukemia.

Authors:
Mark R Litzow

Haematologica 2020 Jun;105(6):1475-1477

Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2020.249110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271610PMC
June 2020

Management of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia.

Ther Adv Hematol 2020 20;11:2040620719899897. Epub 2020 Jan 20.

Division of Hematology and Bone Marrow Transplant, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719899897DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971963PMC
January 2020

Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor.

Blood Adv 2019 12;3(23):4050-4054

Sol Sherry Thrombosis Research Center and Fels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019000756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963253PMC
December 2019

Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.

Echocardiography 2019 11 8;36(11):2033-2040. Epub 2019 Nov 8.

Division of Cardiovascular Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/echo.14518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874906PMC
November 2019

Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.

Nat Commun 2019 11 7;10(1):5051. Epub 2019 Nov 7.

Department of Hematology-Oncology, International Cancer Center, Shenzhen University General Hospital, Shenzhen University Health Science Center, 1098 Xueyuan Ave, 518060, Shenzhen, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-12960-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838331PMC
November 2019

Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia.

Blood Lymphat Cancer 2018 25;8:47-61. Epub 2018 Sep 25.

Division of Hematology, Mayo Clinic, Rochester, MN, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S170351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467350PMC
September 2018

Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.

Biol Blood Marrow Transplant 2019 08 26;25(8):e260-e267. Epub 2019 Mar 26.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.03.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144878PMC
August 2019

No free rides: management of toxicities of novel immunotherapies in ALL, including financial.

Hematology Am Soc Hematol Educ Program 2018 11;2018(1):25-34

Division of Hematology and Bone Marrow Transplant, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2018.1.25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246022PMC
November 2018

No free rides: management of toxicities of novel immunotherapies in ALL, including financial.

Blood Adv 2018 11;2(22):3393-3403

Division of Hematology and Bone Marrow Transplant, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018020198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258912PMC
November 2018

Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Is it imperative in the tyrosine kinase inhibitor era?

Authors:
Mark R Litzow

Best Pract Res Clin Haematol 2018 12 20;31(4):357-360. Epub 2018 Sep 20.

Division of Hematology and Blood and Marrow Transplant, Mayo Clinic, 200 1st Street South West, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.09.004DOI Listing
December 2018

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Biol Blood Marrow Transplant 2019 04 10;25(4):699-711. Epub 2018 Nov 10.

Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota; National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453753PMC
April 2019

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Haematologica 2019 04 31;104(4):844-854. Epub 2018 Oct 31.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2018.200121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442962PMC
April 2019

A dynamic N-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors.

Cell Res 2018 11 8;28(11):1062-1076. Epub 2018 Oct 8.

The Hormel Institute, University of Minnesota, Austin, MN, 55912, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41422-018-0097-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218444PMC
November 2018

Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep 2018 08;13(4):265-274

Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0455-9DOI Listing
August 2018

HDL-AuNPs-BMS Nanoparticle Conjugates as Molecularly Targeted Therapy for Leukemia.

ACS Appl Mater Interfaces 2018 May 18;10(17):14454-14462. Epub 2018 Apr 18.

The Hormel Institute , University of Minnesota , Austin , Minnesota 55912 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.8b01696DOI Listing
May 2018

Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state.

Expert Rev Hematol 2018 03 7;11(3):195-207. Epub 2018 Feb 7.

a Division of Hematology and Bone Marrow Transplant , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1433030DOI Listing
March 2018

Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series.

Mayo Clin Proc 2017 11 1;92(11):1617-1624. Epub 2017 Nov 1.

Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.08.016DOI Listing
November 2017

Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia.

Clin Cancer Res 2017 Oct 18;23(20):6254-6266. Epub 2017 Jul 18.

The Hormel Institute, University of Minnesota, Austin, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641248PMC
October 2017

Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia.

Leuk Lymphoma 2018 01 8;59(1):229-232. Epub 2017 Jun 8.

a Department of Cardiovascular Medicine , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1323268DOI Listing
January 2018

Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2017 Sep 8;23(9):1478-1484. Epub 2017 May 8.

Division of Hematology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.05.001DOI Listing
September 2017

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

J Clin Oncol 2017 Aug 9;35(24):2745-2753. Epub 2017 May 9.

Mikkael A. Sekeres and Aziz Nazha, Cleveland Clinic, Cleveland; Clara D. Bloomfield, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Megan Othus and Anna Moseley, SWOG Statistical Center; Min Fang and Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan F. List, H. Lee Moffitt Cancer Center, Tampa, FL; Olatoyosi Odenike, University of Chicago, Chicago; Mario R. Velasco, Heartland NCORP/Cancer Care Specialists of Central Illinois, Decatur, IL; Richard M. Stone, Dana Farber Cancer Institute; Eyal C. Attar, Massachusetts General Hospital, Boston, MA; Steven D. Gore, Yale University, New Haven, CT; Mark R. Litzow, Mayo Clinic, Rochester, MN; Rena Buckstein, Sunnybrook Health Sciences Centre, Toronto; Elina K. Cook, Alyssa H. Cull, and Michael J. Rauh, Queen's University, Kingston, Ontario, Canada; Diane Roulston, University of Michigan, Ann Arbor, MI; Yanming Zhang, Memorial Sloan-Kettering Cancer Center, New York, NY; Rakesh Gaur, Kansas City National Cancer Institute Community Oncology Research Program, Prairie Village, KS; Ehab Atallah, Medical College of Wisconsin, Milwaukee, WI; and Harry P. Erba, University of Alabama, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.2510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562170PMC
August 2017

Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission?

Authors:
Mark R Litzow

Best Pract Res Clin Haematol 2016 12 20;29(4):345-350. Epub 2016 Oct 20.

Mayo Clinic College of Medicine, Mayo Clinic Comprehensive Cancer Center, 200 First Street SW, Rochester, MN 55905, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.10.009DOI Listing
December 2016

High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

J Clin Oncol 2017 Feb 21;35(4):394-401. Epub 2016 Nov 21.

Kathryn G. Roberts, Zhaohui Gu, Debbie Payne-Turner, Kelly McCastlain, Deqing Pei, Ilaria Iacobucci, Marcus Valentine, Stanley B. Pounds, Lei Shi, Yongjin Li, Jinghui Zhang, Cheng Cheng, and Charles G. Mullighan, St Jude Children's Research Hospital, Memphis, TN; Richard C. Harvey, I-Ming Chen, and Cheryl L. Willman, University of New Mexico Cancer Center, Albuquerque, NM; Alessandro Rambaldi, Manuela Tosi, and Orietta Spinelli, Ospedale Papa Giovanni XXIII, Bergamo, Italy; Jerald P. Radich, Fred Hutchinson Cancer Research Center, Seattle, WA; Mark D. Minden, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Jacob M. Rowe, Shaare Zedek Medical Center, Jerusalem, Israel; Selina Luger, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Mark R. Litzow, Mayo Clinic, Rochester, MN; Martin S. Tallman, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York; Peter H. Wiernik, Cancer Research Foundation of New York; Elisabeth Paietta, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Ravi Bhatia, The University of Alabama at Birmingham, Birmingham, AL; Ibrahim Aldoss and Guido Marcucci, City of Hope, Duarte, CA; Jessica Kohlschmidt, Krzysztof Mrózek, and Clara D. Bloomfield, Comprehensive Cancer Center, The Ohio State University, Columbus, OH; Wendy Stock, University of Chicago Medical Center, Chicago, IL; and Stephen Kornblau, Hagop M. Kantarjian, and Marina Konopleva, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455698PMC
February 2017